Aesthetic Record Acquires JOYA Health to Link Providers with Employee Benefit Programs
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.